Birger Åstedt

No ORCID on file · 5 papers in corpus · active 1981-2009

Study types

  • article 5

Condition tags

  • endometriosis 3
article 2009
Plasminogenaktivatoren bei der Endometriose
·doi:10.1159/000270079
article 1998
Fibrinolysis in the Peritoneal Fluid During Adhesions, Endometriosis and Ongoing Pelvic Inflammatory Disease
Inflammation ·doi:10.1023/a:1022322814288

The concentrations of the specific activators (u-PA and t-PA) and the specific inhibitors (PAI-1 and PAI-2) of the fibrinolytic system were analyzed in the peritoneal fluid in women suffering from intra-abdominal adhesions, endometriosis or…

article 1998
Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00285-4

ObjectiveTo determine whether there is a difference in fibrinolytic compounds in endometriotic tissue, endometrium, peritoneal fluid (PF), and plasma from women with endometriosis and in endometrium and PF from healthy women.DesignProspecti…

article 1984
Plasminogen activators in endometriosis
Acta obstetricia et gynecologica Scandinavica. Supplement ·doi:10.3109/00016348409156976
article 1981
Urokinase-like plasminogen activator as a marker of endometrial neoplasia
·doi:10.1002/1097-0142(19810915)48:6<1484::aid-cncr2820480634>3.0.co;2-l

Urokinase-like plasminogen activator (ULPA) was determined with a radioimmunoassay in uterine aspirates from 67 patients prior to curettage. In women with normal endometrial histology the mean concentration of ULPA was 5.4 +/- 2.5 microgram…